ATIENTS INFECTED with human immunodeficiency
virus (HIV) exhibit not only a decrease of CD4+ peripheral blood (PB) lymphocytes,' but also uni-or rnultilineage suppression of bone marrow (BM) hematopoiesis (ie, thrombocytopenia, granulocytopenia, anemia, lymphopenia), up to pancytopenia in the late stage of HIV infection.2 These hematopoietic disorders are frequently associated with impaired hematopoietic progenitor cell (HPC) growth2 and BM dysplasia, plasmacytosis, and lymphoid Different mechanisms have been suggested to underlie these hematopoietic abnormalities. A suppressive role of anti-HIV gp120 antibodies4 and viral products (ie, tat, nef)"'j has been postulated. The mechanism of the suppressive action is uncertain2: although a direct effect on HPC growth cannot be excluded, several reports indicate indirect mechanisms via infection of BM T cells and/or monocytes,2 which leads to release of a glycoprotein inhibitor, ' an enhanced production of inhibitory cytokines,6.8 and an altered release of hematopoietic growth factor(s) (HGF).'
A key aspect under scrutiny is the capacity of HIV to infect HPCS.~ In this regard, controversial studies have indicated1°"2 or excluded13 the HIV capacity to infect HPCs in vitro. CD34+ hematopoietic cells from acquired immunodeficiency syndrome (AIDS) patients were reportedly either Our studies at single HPC level indicate that a minority of primitive HPCs purified from PB are CD34+/CD4+ and susceptible to HIV-1 infection. P HIV+14-16 or HIv-.5.13.17-21
MATERIALS AND METHODS

HGFs and Culture Medium
Recombinant human interleukin-3 (rhIL-3; 1.7 X IO7 U/mg) and rh granulocyte-macrophage colony-stimulating factor (rhGM-CSF;
Blood, Vol 85, No 5 (March 11, 1995: pp 1181-1187 10 TCID50/cell consistently yielded an 11% to 179'0 infection efficiency of BFU-E-generated colonies, thus indicating the sensitivity of HPCs to in vitro HIV infection. An extensive series of experiments was then performed on HPCs challenged with HIV at 0.1 MO1 level. In the initial studies proviral gag sequences were detected in 9.2% of 121 analyzed CFU-GM colonies. In further experiments tat mRNA was monitored in 17% and 23% of BFU-E and CFU-GM colonies, respectively, but never in CFU-GEMM clones. Finally, 12% of CFU-GM clones and rare erythroid bursts were shown to be positive for the p24 viral protein. In control studies, purified HPCs grown in liquid suspension culture were induced to terminal unilineage erythroid, monocytic, or granulocytic differentiation: monocytes were consistently HIV-infected, whereas mature-terminal erythroblasts and granulocytes were not. Our observations indicate that a minority of primitive HPCs, but not of the multipotent type, is susceptible to in vitro HIV infection. These observations may reflect on the in vivo hematopoietic impairment in AIDS patients; more important, they provide an experimental model for studies on HIV hematopoietic infection and in vitro tests for anti-HIV HSC gene therapy.
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1.7 to 2.5 X IO' U h g ) were supplied by the Genetics Institute (Cambridge, MA), erythropoietin (rhEp) and kit-ligand (rhKL) by Amgen (Thousand Oaks, CA), and Immunex (Seattle, WA), respectively. rhG-CSF and rhM-CSF were purchased from R and D Systems (Minneapolis, MN). Iscove's modified Dulbecco's medium (IMDM; GIBCO, Grand Island, NY) was freshly prepared weekly.
Adult PB
Adult PB was obtained from 20-to 40-year-old healthy male donors after informed consent. Blood, 450 mL % 10%. was collected in preservative-free CPDA-1 anticoagulant (citrate-phosphate-dextrose-adenine). A buffy coat was obtained by centrifugation (Beckman [Palo Alto, CA] J6ME; 1,400 rpm/20 minutes at room temperature). Step 111 purification was potentiated (step HIP) as follows: low-density cells (1.052 and 1.056 fractions) were collected and incubated with appropriate amounts of a cocktail of anti-T (anti-CD2, CD3, CD4, CD7 and CD@, -B (anti-CD19, CD20), -NK lymphocyte (anti-CD16, CD56 and CD57), -monocyte (anti-CD14 and CD36) and -granulocyte (anti-CD1 l b and CDl.5) monoclonal antibodies (MoAbs) as described*' supplemented with anti-CD45, -CDlla, and -CD71 MoAbs (Becton Dickinson, Mountain View, CA). Cells were resuspended in IMDM containing 1 mgfmL bovine serum albumin (BSA; 96% to 99% purified, Fraction V/ No. A4503; Sigma, St Louis, MO), incubated (1 hour at CC) with immunomagnetic monodisperse microspheres coated with sheep antibody to mouse IgG (different subclasses) and IgM (Dynabeads M450; Dynal, Oslo, Norway) at a 4 beadsfcell ratio and then separated with a magnet. Residual cells were then counted and incubated again (1 hour at 4°C) with the same type of magnetic beads at a ratio of 10 beads/cell. Finally, cells were counted again and incubated (30 minutes at 4°C) with magnetic beads coated with affinity purified antimouse IgGl (Fc specific, Dynabeads 110.04; Dynal) at a 10 beadslcell ratio. Throughout this procedure the concentration of magnetic beads never exceeded 50 X lo6 beaddml.
HPC ImmunoJuorescence Analysis
The following MoAbs directly conjugated with fluorochrome For the labeling procedure cells were incubated for 60 minutes at 4°C in the presence of an appropriate amount of MoAb. After three washes with cold phosphate-buffered saline (PBS), cells were resuspended in PBS containing 2.5% formaldehyde and then analyzed by fluorescence-activated cell sorting (FACScan, Becton Dickinson) for fluorescence intensity with a program suitable for double-immunofluorescence analysis. At least 4,000 cells were analyzed for each determination. The gating for analysis of the living cell population was determined by propidium iodide staining.
HPC Assay in Clonogenetic Culture
Purified HPCs were seeded (1 to 2 X 10' cellsfmWdish, two or three plates per point) and cultured in 0.9% methylcellulose, 40% FCS in IMDM supplemented with a-thioglycerol m o m ) (Sigma), ferric ammonium citrate (IO pgfmL) pure human transferrin (0.7 mg/mL), and different HGF as detailed below at 37°C in a 5% C02/5% 02/90% N2 humidified atmosphere.
In FCS-cultures,z2 FCS was substituted by BSA (Fraction V; 10 mg/mL), pure human transferrin (0.7 mg/mL), human low-density lipoproteins (40 pg/ml), insulin (10 pg/mL), sodium pyruvate mom), L-glutamine (2 x mom), rare inorganic elements2' supplemented with iron sulfate (4 X IO-' movt), and nucleosides (10 p g l d of each).
Both FCS' and FCS-cultures were supplemented with KL (100 nglml), IL-3 (100 U), GM-CSF (10 ng or 250 U), and Ep (3 U). Cm-GEMM, BFU-E, and CFU-GM colonies were scored on days 14-15 and 16-18 in FCS' and FCS-culture, respectively.
Virus Preparations
Clarified supernatant from CEMss cells acutely infected with lymphotropic HIV-l, HTLVIIIB strainz4 titrating 3 X lo6 TCIDd mL (tissue culture infectious dose 50%, TCIDso), was routinely used for the infection.
Clarified supernatant from CEMss cells transfected with pNL4-3 lymphomonocytotropic HIV-1 infectious molecular clone'' was purified. Briefly, 300 mL of HIV-transfected CEMss supernatant was first pelletted for 2 hours at 25,000 rpm and resuspended in PBS. The concentrated virus preparation was then loaded onto a 30% sucrose cushion and run for 6 hours at 40,000 rpm. The pellet was resuspended in PBS, loaded onto a 20% to 60% linear sucrose gradient and run for 20 hours at 40,000 rpm. The gradient fractions were finally titrated. HIV titer (TCIDSo) was determined by infecting quadruplicate C8166 cells with 10-fold serial dilutions of viral preparation and measuring the cytopathic effect as shown by syncytia formation 4 to 5 days postinfection. A purified HIV N U -3 titrating lo4 TCIDSdmL was obtained and used to infect HPCs in selected experiments, as specified below.
HPC Infection and Growth in Unicellular Culture
CD34+ HPCs, 1 X IO4, maintained overnight in liquid culture (5 X lo4 cellsfml) supplemented with KL, IL-3, GM-CSF 2 Ep at saturating dosage (see below), were then pelletted and resuspended in a maximum volume of 50 p L in the presence of the appropriate HIV MOL As a negative control, cells were mock-treated or incubated with either heat-inactivated virus (65°C for 1 hour) or supematant from the 8E.5 HIV-l chronically infected cell line releasing noninfectious viral particles.26 After a 2-hour adsorption at 37°C under shaking, complete medium was added to reach a volume of 0.2 mL. Cells were incubated overnight at 37°C in a 5% CO2, 5 % Oz, 90% NI humidified atmosphere. Cells were then extensively washed, diluted (5 cellsfml) in semisolid medium containing 0.9% methylcellulose, 40% FCS in IMDM supplemented with a-thioglycerol ( mom) (Sigma), KL (100 ng/mL), IL-3 (100 U), GM-CSF (10 ng), and Ep (3 U) (in some experiments Ep was not added). After gentle mixing l00 pL of the cell suspension was seeded in single wells (96 flat-bottom wellsfplate; Falcon) and incubated as indicated above. Colonies were scored after 14 to 17 days under an inverted microscope (Zeiss, Oberkochen, Germany) and picked up for morphologic or polymerase chain reaction (PCR)/reverse transcriptase-PCR (RT-PCR) analysis.
Infection of HPC-Generated Erythroid, Granulocytic, and Monocytic Cells
Step 111 HPCs were grown in liquid suspension cultures (5 X IO4 cellsfml) for selective erythroid, granulocytic, or monocytic differentiation. In erythroid differentiation FCS-culture, very low doses of IL-3 (0.01 U/mL) and GM-CSF (0.001 ng/mL) and plateau level of Ep (3 UfmL) were added. Granulopoietic FCS-culture medium was supplemented with low doses of IL-3 (1 UfmL) and GM-CSF (0.1 ng or 2.5 U) and plateau-level G-CSF (500 U). Monocytic differentiation culture medium contained LMDM, 40% FCS, and M-CSF (500 UfmL). Cells were cultured for 12 (FCS') or 15 (FCS-) days and periodically diluted to 5 X 10' cellsfmL; thereafter, they were HIV-infected as described above, cultured until day 14 (FCS+) or 17 (FCS-), and analyzed by RT-PCR. PCR. Single colonies were washed in PBS and digested with pmteinase K (60 pg/mL,) in 0.3% N P 4 , 10 mmoK NaCI, 3 mol/L MgCl,, 20 m K TRIS, 0.4% Tween for 60 minutes at 56°C. The proteinase was then inactivated at 95°C for 5 to 10 minutes. After digestion the samples were spun down, and the supernatant stored at 4°C until amplified. PCR parameters were as described for RT-PCR.
PCR Analysis
PCR products were run on 1.8% agarose gel and transferred onto nitrocellulose membrane. Filters were hybridized using an end-labeled probe and then autoradiogaphed at -80°C.
The PCR primers recognizing a conserved region of the gag sequence were: sense 5'AGAGATGGGTGCGAGAGCGT3', antisense 5'GTCTAAAGCTTCCTTGGTGTC3', and the specific probe 5'GGGCAAGCAGGGAGCTAG3'.28 The RT-PCR primers recognizing a conserved tat sequence were: sense S'CGCAGGCTCGGC-'lTGCTGAA3', antisense S'CTATTCCTTCGGGCCTGTCG3', and the specific probe 5'GAGCCAGTAGATCCTAGACAGAGC3'.29
The primers used for &microglobulin cDNA were: sense SAACCACGTGACTlTGTCACAGC3'. antisense S'CTGCTCAGATAC-ATCAAACATG3', and the probe was a 35-bp oligonucleotide comprised in the amplified 251-bp fragmentM
p24 EUSA
Evaluation of intracellular p24 antigen was performed by lysing single colonies in 200 pL of 7'NE buffer (10 mmol/L TRIS, 100 mmoYL NaCI, 1 mmoYL EDTA, pH 7.4) containing 0.1% of Triton X-100. After 5 minutes of incubation on ice, cell lysates were briefly spun and supernatants were tested by ELISA (Antigen Capture Assay; Abbott, North Chicago, E).
RESULTS
HPCs were stringently purified from normal adult PB using a procedurez3 recently modified by a potentiated negative selection (step IIIP) to improve W C recoveryz2: in five separate experiments the frequency of step IIIP HPCs (CFU-GEMM + BFU-E + CFU-GM) in clonogenetic assay was 80.0 2 2.7 (mean I SEM values) (Fig 1) .
The membrane phenotype of step IDP cells was evaluated by double immunofluorescence for the expression of CD34 and CD4 antigens (representative results in Fig  2) . This analysis showed that (1) greater than 9 0 % of step IIIF' cells are CD34+ (see also Fig 1) ; (2) a low proportion of CD34+ cells displays a dim but significant reactivity with PE-labeled anti-CD4 MoAb: in five different experiments the range of CD34+/CD4+ cells was between 5% and 20% (two representative experiments are shown in Fig 2) ; (3) this CD34+/CD4+ cell population was monitored when anti-CD4 MoAb was included ( a s routinely performed, see Fig 2, top and middle panels) or excluded (Fig 2,  bottom panel) in the MoAb cocktail used for step IIJP negative selection. In the latter case (bottom panel), a small population of CD34-/CD4+ T lymphocyte was observed (the majority of T cells was presumably eliminated by the anti-CD3, -CD7 MoAbs always included in the cocktail). These results indicate that anti-CD4 MoAb removes C M + lymphocytes which exhibit a high CD4 density, while it spares CD34+/CJM+ HPC showing low CD4 density.
Initially, control studies were performed to validate the HIV-1 infection procedure.
Step IIIP HPCs were grown in liquid suspension culture to induce unilineage differentiation UP to terminal monocytic, granulocytic, or erythroid matura- tion and then infected with W -3 or HTLVIIIB HIV-1 strain (results with NU-3 are presented in Fig 3; identical results were obtained with the HTLVIIIB strain, not shown): (1) monocytic cultures, composed by a majority of monocytes/ macrophages exhibiting typical monocytic markers (ie, CD14 antigen), were consistently HIV-infected as evaluated by RT-PCR analysis; (2) granulopoietic cultures, containing a large majority of neutrophils (>90%) and displaying typical granulocytic markers (eg, CD1 lb) were not infected by HIV-1 ; (3) erythroid cultures, mainly composed by matureterminal erythroblasts (98%) expressing the erythroid marker glycophorin A, were HIV-1 negative by RT-PCR.
Purified step IIIP cells were incubated with a graded HIV/ cell ratio (HTLVIIIB strain, TCID&ell) from 0.01 : 1 to 10: 1 (Fig 4) . Control cells were incubated with (1) the supernatant obtained from 8E.5, a chronically infected cell line releasing noninfectious viral particles, (2) heat-inactivated virus, or (3) were mock-treated. The cells were then grown at 0.5 celYwell in semisolid culture in the presence of KL, IL-3, GM-CSF, and Ep. BFU-E colonies were analyzed after 14 days. At all MO1 levels, the presence of tat mRNA was detected in 11% to 17% of the BFU-E colonies, but not in the three control groups.
In a subsequent series of expehents, step IIIP cells were HIV-challenged (HLTWIB strain, 0.1 TClD&ell) and then cultured in the presence of KL, E-3, GM-CSF, and Ep. A limiting dilution cell cloning was performed (0.5 CelYwell). Single colonies plucked after 14 to 17 days of incubation were analyzed for the presence of specific tat mRNA sequences with &-microglobulin mRNA as internal control: interestingly, 17.3% t 1.8% and 22.6% t 3.7% (mean +: SEM values) of BFU-E and CFU-GM clones, respectively, were rut+, whereas CFU-GEMM colonies were always negative, as observed for mock-or 8E.5-treated controls (Fig 5A and B, middle panels) .
In other experiments step IIIP cells were infected with purified or nonpurified HIV (NL4-3 or HTLVIIIB strain, respectively, 0.1 TCID&ell) and then grown in the presence of KL, IL-3, and GM-CSF (Ep was either added or not). Individual GM and BFU-E colonies were analyzed by PCR for the presence of proviral gag sequence. In a representative experiment with the N U -3 strain, 9.2% 2 1.3% of CFU-GM colonies were HIV' (Fig 5B, left panel) ; similar results were obtained on BFU-E colonies (results not shown). In experiments with the same NL4-3 challenge, we assayed single colonies obtained in single-cell culture for viral p24: p24 was detected in only 1 of 37 BFU-E colonies, whereas 4 of 33 CFU-GM colonies were positive (Fig 5B, right panel) .
DISCUSSION
The significance of previous reports on in vitro HIV infection of HPCs, yielding either or negative results,'3 is uncertain. Positive studies have been performed on CD34' partially purified HPCs, which were then grown in bulk cultures: because the presence of monocytic cells in the infected and cultured cell population was not excluded, the HIV capacity to infect HPCs rather than the contaminating monocytic cells was not established.' Negative studies13 were performed on unpurified BM HPCs infected and then grown in clonogenetic culture: HIV sequences in the individual colonies were not demonstrated by PCR analysis.
In view of these ambiguities, we have developed methodology for HIV infection of single HPCs and HIV detection in their clonal progeny. Thus, early HPCs were -80% purified from PBZ2**': their membrane phenotype (CD34+/33-/ nies."-" indicate their early stage of differentiation. The purified HPCs were HIV-infected and then cloned in methylcellulose culture at a seeding density of 0.5 cell/well, thus excluding presence of two or more cells in a single well. In an extensive series of experiments, this procedure consistently caused HIV-l infection of 9% to 23% of BFU-E and CFU-GM, as evaluated in their clonal progeny by PCR, RT-PCR, and ELISA (except for ELISA of erythroid bursts, see below). It is noteworthy that (1) we have used both unpurified and purified HIV isolates, namely the HTLVIIIB and NU-3 strains, respectively: both strains yielded equivalent results for HPC and monocyte infections (the NL4-3 strain showed a more expanded tropism" compared with the preferentially lymphotropic HTLVIIIB strain,24 but Folks et all0 showed the ability of HTLVIIIB to infect human hematopoietic precursors maturing to monocytes); (2) both inactivated HIV and an HIV mutant with loss of infectivity were included in the controls; (3) a large dosage range was used: interestingly, the HPCs were effectively infected even at low MO1 level; (4) the HIV infection of the single HPC progeny was evaluated at both DNA and RNA level by gag PCR and rut RT-PCR, respectively (the latter was performed with primers through large spliced sequences to exclude PCR of viral RNA or DNA sequences absorbed onto the analyzed cells); (5) 12% of the CFU-GM clones were positive for p24, as evaluated by ELISA. (6) The efficiency of the HIV infection system was further validated by infection of HPCgenerated terminal monocytic cells versus lack of infection of HPC-generated terminal erythroid and granulocytic cells.
A minority of CD34' HPCs coexpress the CD4 antigen, thus in line with a previous report on the presence of CD4 45RA-/71-)2'.31-" and the large size of the derived colo-on murine stem cells. 35 The possibility exists that CD4 on HPC membrane functions as the portal entry for HIV, although other mechanism(s) cannot be excluded. Ongoing studies aim to verify the HIV infection susceptibility of sorted CD34+/CD4' versus CD34'/CD4-HPCs.
HIV infection has been observed for both BFU-E and CFU-GM colonies, but not for the mixed clones: the latter finding suggests that HIV susceptibility is dependent on the stage of HPC differentiation.
The 12% frequency of p24' CFU-GM clones is close to
El El the 23% incidence of rur-mRNA' CFU-GM colonies. Conversely, the rarity of p24+ BFU-E clones ( 1 of 37) compares with the 17% frequency of tar-mRNA' BFU-E colonies: the very low incidence of p24+ BFU-E clones may be attributed at least in part to hampered HIV expression in erythroid cells at translational level.
One interpretation of our results might be that HIV is first absorbed on the HPC membrane, possibly on the CD4 antigen, and then infects the HPC-derived monocytic progeny. This remote possibility is in contrast with several aspects: (1) the infected HPC population is extensively washed before clonogenetic culture; (2) HIV sequences are present in BFU-E colonies, which comprise less than 0.5% to 1% monocytic cells (results not shown); (3) the frequency of BFU-E colony infection is similar to that of CFU-GM colonies, which contain a high number of monocytic cells; (4) mixed colonies, while comprising a large monocytic component, are always HIV-.
The discrepancy between our positive results and the negative ones by Molina et all3 may be reconciled by the sharp difference of the HIV-infected cell populations (ie, 80% purified early HPCs [our studies] or light density, T-cell-depleted BM cells comprising < O S % early HPCsI3) and/or the culture conditions (ie, presence [our studies] or absencet3 of IL-3 and KL stimulus, which favors HPC survival and pr~liferation".~~). It is possible that in the negative studiesI3 the HIV challenge was preferentially absorbed on the vast majority of non-HPC cells, thus preventing the HIV particles to effectively interact with HPCs and hence to infect them and their clonal progeny. Alternatively or additionally, HPC infection in absence of IL-3 and K L I 3 may have caused HPC necrobiosis or impaired clonogenesis (see also below).
The present observations reflect on the in vivo impairment of hematopoiesis in HIV-infected patients. Our findings on in vitro HIV infection of 10% to 20% of early HPCs are not necessarily in contrast with reports indicating that in AIDS patients CD34' cells are HIV-.5~13~17-2' Indeed, (1) the in vivo HIV infected HPCs may represent a small subfraction of the early HPC pool and a much smaller subset of the CD34+ cell population, thus rendering difficult the detection of very few HIV+ early HPCs in CD34' cells; furthermore, (2) it cannot be excluded that the HIV' HPCs undergo necrobio- sis: in line with the latter postulate, we observed that the purified HPCs challenged with HIV-1 at the routinely used MO1 level (0.1 TCIDSo) and grown in unicellular culture generate on the average a 39% lower number of colonies than mock controls. On the other hand, the number of HIV' HPCs may sharply increase in advanced AIDS because of widespread HIV infection, thus explaining the reports on in vivo HIV' CD34' cells in the advanced d i~e a s e . '~"~ In conclusion, the present studies may shed light on the mechanism(s) of hematopoietic impairment in AIDS patients. More importantly, they provide a novel experimental tool to (1) explain the interaction of HIV with hematopoietic cells, particularly in the early stages of differentiation, and to (2) test anti-HIV HSC gene therapy.
